OncoNano Announces Completion of Phase 1a Study and Expands into Phase 1b for Intraoperative Imaging Agent to Detect Tumors and Metastatic Lymph Nodes That Often Go Undetected During Surgery By Daniel MurilloPress Releases Results Selected for Poster presentation at San Antonio Breast Cancer Symposium SOUTHLAKE, TX. –December 5,...Read More December 5, 2018 Love0
OncoNanoAnnounces Dosing of Patientsin Phase 1 Clinical Trial with ONM-100, an Intraoperative Imaging Agent that Targets Tumor Acidosisforthe Detection of Solid Tumors By Daniel MurilloPress Releases The study, being conducted at TRACER Center of Expertise, University Medical Center in Groningen, The...Read More July 10, 2018 Love0
OncoNano Announces $11.7 Million Series A Financing to Support Development of pH-activated Compound Platform for Disease Detection and Treatment By Daniel MurilloPress Releases SOUTHLAKE, TX. – May 17, 2018 – OncoNano Medicine, Inc. today announced the closing of...Read More May 17, 2018 Love0
